CVS HEALTH Corp
CVSRetail-Drug Stores and Proprietary Stores · SIC 5912 · CIK 0000064803
Revenue FY2025
$402.07B
Net Income
$1.77B
EPS (Basic)
$1.40
Net Margin
0.4%
ROE
2.4%
Total Equity
$75.21B
Shares Out
1.28B
CVS HEALTH Corp — Retail-Drug Stores and Proprietary Stores. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 21 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Fairfax Financial Holdings
Prem Watsa
$0.28B
10.6%
—
Glenview Capital Management
Glenview Capital Management
$0.50B
7.8%
(41.1%)
Patient Capital Management
Samantha McLemore
$0.13B
5.1%
(9.0%)
Davis Advisors
Christopher Davis
$1.23B
4.8%
(3.1%)
Hillman Capital Management
Hillman
$0.01B
2.9%
(17.8%)
Pzena Investment Management
Richard Pzena
$1.22B
1.5%
(14.5%)
Dodge & Cox
Dodge & Cox
$5.17B
1.1%
(3.4%)
Capital World Investors
Capital World Investors
$7.75B
0.9%
(3.0%)
Olstein Capital Management
Robert Olstein
$0.00B
0.6%
(10.7%)
Holocene Advisors
Holocene Advisors
$0.31B
0.6%
(33.0%)
Ariel Investments
John Rogers
$0.08B
0.6%
+4.0%
Viking Global Investors
Andreas Halvorsen
$0.38B
0.5%
NEW
Motley Fool Asset Management
Motley Fool Asset Management
$0.01B
0.4%
(7.8%)
Capital Research Global Investors
Capital Research Global Investors
$2.52B
0.4%
+21.6%
Adage Capital Management
Adage Capital Management
$0.17B
0.2%
+2.7%
Suvretta Capital Management
Suvretta Capital Management
$0.01B
0.2%
NEW
Alps Advisors
Alps Advisors
$0.03B
0.1%
(19.5%)
Renaissance Technologies
Renaissance Technologies
$0.05B
0.0%
+67.6%
Matrix Asset Advisors
David Katz
$0.00B
0.0%
—
Oakmark Funds (Harris Associates)
Bill Nygren
$0.03B
0.0%
(32.0%)
Bridgewater Associates
Bridgewater Associates
$0.05B
0.0%
(28.7%)
Insider Transactions
Reading stored insider transactions…